Sudhir Choudhrie was born in India and raised in London, England. He graduated from the London School of Economics and Political Science (L.S.E. ), gaining a BSc in International Relations. He studied at the University of Mumbai in India (1st Class Honours degree) and at Harvard University’s Kennedy School of Government in the United States. He completed executive education programs at Harvard Business School and the Stanford Graduate School of Business (S.G.S.B.).
Sudhir Choudhrie began his business career with the Hinduja Group, India, in 1978, after finishing his university studies. In the early 1980s, he was assigned to Hinduja Brothers Ltd. in Hong Kong as a Director, where he oversaw their Middle East operations. In 1984, Sudhir became a founding partner of Choudhrie & Lahoti, an Indian-based conglomerate with offices in Delhi and Mumbai. He held senior positions within the group, including joint managing director (CEO) and group chairman.
C&C Alpha Group
In the mid-1990s, Sudhir developed an interest in global healthcare and established Cygnet Healthcare. This company was a joint venture between J.S.J.S. International (a leading global healthcare logistics provider) and Alpha Hospitals Ltd. During his leadership, Cygnet expanded from India to establish subsidiaries in the Middle East, Africa, and North America. Cygnet was a profitable business that Sudhir sold to Cygnet Healthcare Group, also based in Delhi and Mumbai, for US$78 million in 2006; at that time, Sudhir entered into a strategic partnership with Oxford Health Investors (OHI) to purchase Alpha Hospitals, which later became C&C Health Group P.L.C.
Sudhir Choudhrie has played an active role in the development of Alpha Hospitals since 2007. In June 2010,Sudhir Choudhrie led a consortium of investors to acquire C&C Alpha Group for £217 million. Today, C&C Alpha has over 7,000 staff and works with 140 NHS hospitals across the U.K. Under Sudhir’s leadership, he initiated a Group Comprehensive Healthcare Review (C.H.C.R.), which included developing a diversified portfolio of healthcare services with global supply chain synergies, leveraging economies of scale on operational costs, and providing access to new markets.